Brief info

Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions. We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines. Our vision is to live in a world in which no one dies or suffers from a vaccine-preventable disease. More information is available at www.valneva.com.

Funded by the European Union under EDCTP3 (EAVI – Global Health EDCTP3 – European Union). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.

EUROPEAN-AFRICAN VACCINE INITIATIVE (EAVI) © All Rights Reserved.

to top